dc.contributor.author
Ariza Solé, Albert
dc.contributor.author
Sánchez Salado, Jose Carlos
dc.contributor.author
Lorente, Victòria
dc.contributor.author
Sánchez Elvira, Guillermo
dc.contributor.author
Muntané, Guillem
dc.contributor.author
Salazar Mendiguchía, Joel
dc.contributor.author
Cequier Fillat, Àngel R.
dc.date.accessioned
2025-12-13T10:48:18Z
dc.date.available
2025-12-13T10:48:18Z
dc.date.issued
2025-12-12T11:19:37Z
dc.date.issued
2025-12-12T11:19:37Z
dc.date.issued
2014-02-15
dc.date.issued
2025-12-12T11:19:37Z
dc.identifier
https://hdl.handle.net/2445/224856
dc.identifier.uri
https://hdl.handle.net/2445/224856
dc.description.abstract
Both intensive antithrombotic therapy and an early invasive strategy reduce the incidence of ischemic events in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS), at the expense of increasing the rate of bleeding complications. Current recommendations [1] emphasize the use of an early invasive strategy in patients at higher risk. However, most registries show a more conservative management in these patients
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: http://doi.org/10.1016/j.ijcard.2013.11.065
dc.relation
International Journal of Cardiology, 2014, vol. 171, num.3, p. 448-450
dc.relation
http://doi.org/10.1016/j.ijcard.2013.11.065
dc.rights
(c) Elsevier B.V., 2014
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Malalties coronàries
dc.subject
Coronary diseases
dc.title
Is it possible to separate ischemic and bleeding risk in patients with non-ST segment elevation acute coronary syndromes?
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
